Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifeway Foods (LWAY) Asset Writedowns and Impairment (2016 - 2021)

Historic Asset Writedowns and Impairment for Lifeway Foods (LWAY) over the last 10 years, with Q4 2021 value amounting to -$4000.0.

  • Lifeway Foods' Asset Writedowns and Impairment fell 3333.33% to -$4000.0 in Q4 2021 from the same period last year, while for Sep 2023 it was -$4000.0, marking a year-over-year decrease of 30000.0%. This contributed to the annual value of $2000.0 for FY2023, which is N/A changed from last year.
  • Latest data reveals that Lifeway Foods reported Asset Writedowns and Impairment of -$4000.0 as of Q4 2021, which was down 3333.33% from $7000.0 recorded in Q3 2021.
  • In the past 5 years, Lifeway Foods' Asset Writedowns and Impairment ranged from a high of $309000.0 in Q3 2018 and a low of -$229000.0 during Q4 2019
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $7000.0 (2021), whereas its average is $51684.2.
  • As far as peak fluctuations go, Lifeway Foods' Asset Writedowns and Impairment plummeted by 94090.91% in 2019, and later surged by 60000.0% in 2021.
  • Over the past 5 years, Lifeway Foods' Asset Writedowns and Impairment (Quarter) stood at $160000.0 in 2017, then crashed by 113.75% to -$22000.0 in 2018, then crashed by 940.91% to -$229000.0 in 2019, then soared by 98.69% to -$3000.0 in 2020, then crashed by 33.33% to -$4000.0 in 2021.
  • Its Asset Writedowns and Impairment stands at -$4000.0 for Q4 2021, versus $7000.0 for Q3 2021 and -$1000.0 for Q2 2021.